Stepwise reprogramming of liver cells to a pancreas progenitor state by the transcriptional regulator Tgif2
- PMID: 28193997
- PMCID: PMC5316826
- DOI: 10.1038/ncomms14127
Stepwise reprogramming of liver cells to a pancreas progenitor state by the transcriptional regulator Tgif2
Abstract
The development of a successful lineage reprogramming strategy of liver to pancreas holds promises for the treatment and potential cure of diabetes. The liver is an ideal tissue source for generating pancreatic cells, because of its close developmental origin with the pancreas and its regenerative ability. Yet, the molecular bases of hepatic and pancreatic cellular plasticity are still poorly understood. Here, we report that the TALE homeoprotein TGIF2 acts as a developmental regulator of the pancreas versus liver fate decision and is sufficient to elicit liver-to-pancreas fate conversion both ex vivo and in vivo. Hepatocytes expressing Tgif2 undergo extensive transcriptional remodelling, which represses the original hepatic identity and, over time, induces a pancreatic progenitor-like phenotype. Consistently, in vivo forced expression of Tgif2 activates pancreatic progenitor genes in adult mouse hepatocytes. This study uncovers the reprogramming activity of TGIF2 and suggests a stepwise reprogramming paradigm, whereby a 'lineage-restricted' dedifferentiation step precedes the identity switch.
Conflict of interest statement
The authors declare no competing financial interests.
Figures
Similar articles
-
JMJD3 aids in reprogramming of bone marrow progenitor cells to hepatic phenotype through epigenetic activation of hepatic transcription factors.PLoS One. 2017 Mar 22;12(3):e0173977. doi: 10.1371/journal.pone.0173977. eCollection 2017. PLoS One. 2017. PMID: 28328977 Free PMC article.
-
The organoid-initiating cells in mouse pancreas and liver are phenotypically and functionally similar.Stem Cell Res. 2014 Sep;13(2):275-83. doi: 10.1016/j.scr.2014.07.006. Epub 2014 Jul 27. Stem Cell Res. 2014. PMID: 25151611 Free PMC article.
-
Molecular mechanisms of transcription factor mediated cell reprogramming: conversion of liver to pancreas.Biochem Soc Trans. 2021 Apr 30;49(2):579-590. doi: 10.1042/BST20200219. Biochem Soc Trans. 2021. PMID: 33666218 Free PMC article. Review.
-
The Gata5 target, TGIF2, defines the pancreatic region by modulating BMP signals within the endoderm.Development. 2008 Feb;135(3):451-61. doi: 10.1242/dev.008458. Epub 2007 Dec 19. Development. 2008. PMID: 18094028
-
Direct Lineage Reprogramming: Harnessing Cell Plasticity between Liver and Pancreas.Cold Spring Harb Perspect Biol. 2020 Jul 1;12(7):a035626. doi: 10.1101/cshperspect.a035626. Cold Spring Harb Perspect Biol. 2020. PMID: 31767653 Free PMC article. Review.
Cited by
-
TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness.Signal Transduct Target Ther. 2019 Dec 13;4:60. doi: 10.1038/s41392-019-0098-x. eCollection 2019. Signal Transduct Target Ther. 2019. PMID: 31871777 Free PMC article.
-
Direct reprogramming of human Sertoli cells into male germline stem cells with the self-renewal and differentiation potentials via overexpressing DAZL/DAZ2/BOULE genes.Stem Cell Reports. 2021 Nov 9;16(11):2798-2812. doi: 10.1016/j.stemcr.2021.09.011. Epub 2021 Oct 14. Stem Cell Reports. 2021. PMID: 34653405 Free PMC article.
-
Chemical Cocktails Enable Hepatic Reprogramming of Mouse Fibroblasts with a Single Transcription Factor.Stem Cell Reports. 2017 Aug 8;9(2):499-512. doi: 10.1016/j.stemcr.2017.06.013. Epub 2017 Jul 27. Stem Cell Reports. 2017. PMID: 28757167 Free PMC article.
-
The potential and challenges of alternative sources of β cells for the cure of type 1 diabetes.Endocr Connect. 2018 Mar;7(3):R114-R125. doi: 10.1530/EC-18-0012. Endocr Connect. 2018. PMID: 29555660 Free PMC article. Review.
-
TGIF2 is a potential biomarker for diagnosis and prognosis of glioma.Front Immunol. 2024 Feb 26;15:1356833. doi: 10.3389/fimmu.2024.1356833. eCollection 2024. Front Immunol. 2024. PMID: 38629068 Free PMC article.
References
-
- Graf T. & Enver T. Forcing cells to change lineages. Nature 3, 587–594 (2009). - PubMed
-
- Jopling C., Boue S. & Izpisua Belmonte J. Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration. Nat. Rev. Mol. Cell Biol. 12, 79–89 (2011). - PubMed
-
- Slack J. M. Metaplasia and transdifferentiation: from pure biology to the clinic. Nat. Rev. Mol. Cell Biol. 8, 369–378 (2007). - PubMed
-
- Heinrich C., Spagnoli F. & Berninger B. Recent breakthroughs and future challenges in in vivo reprogramming for tissue repair. Nat. Cell Biol. 17, 204–211 (2015). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
